3 patents
Utility
Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes
3 Oct 23
The present disclosure provides, inter alia, engineered microbes expressing recombinant LEKTI domains that are effective to treat or ameliorate the symptoms of Netherton Syndrome.
Travis Michael Whitfill, Azim Momin Munivar
Filed: 15 Jun 18
Utility
Auxotrophic strains of
22 Jun 21
The present disclosure provides recombinant Staphylococcus bacterium (e.g.
Travis Michael Whitfill, Ming-De Deng, David Richard Dodds, Alexander Tikhonov
Filed: 4 Jan 19
Utility
Therapeutic treatment of skin disease with recombinant commensal skin microorganisms
6 Jul 20
The invention relates to methods for treating or preventing abnormal skin conditions in a human in need thereof, comprising administering a cell culture composition comprising a living culture of bacteria comprising at least one engineered strain that produces a recombinant polypeptide for therapeutic treatment of the abnormal skin condition.
Azim Momin Munivar, Travis Michael Whitfill
Filed: 27 May 15
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first